Farmer to pharmacist: Curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer

Frontiers in Chemistry

Volumn 2, Issue DEC, 2014, Pages

  Bandyopadhyay, Debasish ^a  

^a UNIVERSITY OF TEXAS PAN AMERICAN   (United States)

Author keywords

Adenocarcinoma; Angiogenesis; Cancer; Carcinoma; Curcumin; Invasion; Metastasis; Polyphenol

Indexed keywords

EID: 84987638033     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2014.00113     Document Type: Review

References (79)

1. Aggarwal, B. B., Sundaram, C., Malani, N., and Ichikawa, H. (2007). Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595, 1-75. doi: 10.1007/978-0-387-46401-5_1
2. Ammon, H. P. T., and Wahl, M. A. (1991). Pharmacology of Curcuma longa. Planta Med. 57, 1-7. doi: 10.1055/s-2006-960004
3. Anand, P., Kunnumakkara, A. B., Newman, R. A., and Aggarwal, B. B. (2007). Bioavailability of curcumin: problems and promises. Mol. Pharm. 4, 807-818. doi: 10.1021/mp700113r
4. Bandyopadhyay, D., and Banik, B. K. (2012). Bismuth nitrate-induced microwave-assisted expeditious synthesis of vanillin from curcumin. Org. Med. Chem. Lett. 2:15. doi: 10.1186/2191-2858-2-15
5. Basnet, P., and Skalko-Basnet, N. (2011). Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16, 4567-4598. doi: 10.3390/molecules16064567
6. Cen, L., Hutzen, B., Ball, S., DeAngelis, S., Chen, C. L., Fuchs, J. R., et al. (2009). New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells. BMC Cancer 9:99. doi: 10.1186/1471-2407-9-99
7. Charpentier, M. S., Whipple, R. A., Vitolo, M. I., Boggs, A. E., Slovic, J., Thompson, K. N., et al. (2014). Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res. 74, 1250-1260. doi: 10.1158/0008-5472.CAN-13-1778
8. Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., and Banerjee, R. K. (2004). Turmeric and curcumin: biological actions and medicinal applications. Curr. Sci. 87, 44-53.
9. Chaudhri, K. R. C. (1950). Turmeric, haldi or haridra, in eye disease. Antiseptic. 47, 67.
10. Chen, H. W., Lee, J. Y., Huang, J. Y., Wang, C. C., Chen, W. J., Su, S. F., et al. (2008). Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res. 68, 7428-7438. doi: 10.1158/0008-5472.CAN-07-6734
11. Chen, H. W., Lee, J. Y., Huang, J. Y., Wang, C. C., Chen, W. J., Su, S. F., et al. (2014). Curcumin inhibits lung cancer cell migration and invasison through Rac1-dependent signaling pathway. J. Nutr. Biochem. 25, 177-185. doi: 10.1016/j.jnutbio.2013.10.004
12. Chiablaem, K., Lirdprapamongkol, K., Keeratichamroen, S., Surarit, R., and Svasti, J. (2014). Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition. Anticancer Res. 34, 1857-1864.
13. Chiu, T. L., and Su, C. C. (2009). Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-k Bp65 expression in breast cancer MDA-MB-231 cells. Int. J. Mol. Med. 23, 469-475. doi: 10.3892/ijmm_00000153
14. Epstein, J., Sanderson, I. R., and MacDonald, T. T. (2010). Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Brit. J. Nutr. 103, 1545-1557. doi: 10.1017/S0007114509993667
15. Faguet, G. B. (2014). A brief history of cancer: Age-old milestones underlying our current knowledge database. Int. J. Cancer. doi: 10.1002/ijc.29134. [Epub ahead of print].
16. Goel, A., Kunnumakkara, A. B., and Aggarwal, B.B. (2008). Curcumin as "Curecumin": from kitchen to clinic. Biochem. Pharmacol. 75, 787-809. doi: 10.1016/j.bcp.2007.08.016
17. Gupta, A., Zhou, C. Q., and Chellaiah, M. A. (2013a). Osteopontin and MMP9: associations with VEGF expression/secretion and angiogenesis in PC3 prostate cancer cells. Cancers 5, 617-638. doi: 10.3390/cancers5020617
18. Gupta, G. P., and Massagué, J. (2006). Cancer metastasis: building a framework. Cell 127, 679-695. doi: 10.1016/j.cell.2006.11.001
19. Gupta, S. C., Patchva, S., Koh, W., and Aggarwal, B. B. (2012). Discovery of curcumin, a component of the golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol. 39, 283-299. doi: 10.1111/j.1440-1681.2011.05648.x
20. Gupta, S. C., Sung, B., Kim, J. H., Prasad, S., Li, S., and Aggarwal, B. B. (2013b). Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol. Nutr. Food Res. 57, 1510-1528. doi: 10.1002/mnfr.201100741
21. Ha, Y. R., Choi, Y. W., and Lee, S. J. (2011). Critical role of plectin in anti-migration potential of curcumin. Food Sci. Biotechnol. 20, 1615-1624. doi: 10.1007/s10068-011-0223-2
22. Han, X., Xu, B., Beevers, C. S., Odaka, Y., Chen, L., Liu, L., et al. (2012). Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 33, 868-875. doi: 10.1093/carcin/bgs029
23. Hasima, N., and Aggarwal, B. B. (2012). Cancer-linked targets modulated by curcumin. Int. J. Biochem. Mol. Biol. 3, 328-351.
24. Hatcher, H., Planalp, R., Cho, J., Torti, F. M., and Torti, S. V. (2008). Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 65, 1631-1652. doi: 10.1007/s00018-008-7452-4
25. Hendrayani, S. F., Al-Khalaf, H. H., and Aboussekhra, A. (2013). Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects. Neoplasia 15, 631-640. doi: 10.1593/neo.13478
26. Herman, J. G., Stadelman, H. L., and Roselli, C. E. (2009). Curcumin blocks CCL2-induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity. Int. J. Oncol. 34, 1319-1327. doi: 10.3892/ijo_00000259
27. Huang, T., Chen, Z., and Fang, L. (2013). Curcumin inhibits LPS-induced EMT through downregulation of NF-k B-Snail signaling in breast cancer cells. Oncol. Rep. 29, 117-124. doi: 10.3892/or.2012.2080
28. Jiang, T. L., Salmon, S. E., and Liu, R. M. (1983). Activity of camptothecin, harringtonin, cantharidin and curcumae in the human tumor stem cell assay. Eur. J. Cancer Clin. Oncol. 19, 263-270. doi: 10.1016/0277-5379(83)90425-X
29. Kim, H. I., Huang, H., Cheepala, S., Huang, S., and Chung, J. (2008). Curcumin inhibition of integrin (α6β 4)-dependent breast cancer cell motility and invasion. Cancer Prev. Res. 1, 385-391. doi: 10.1158/1940-6207.CAPR-08-0087
30. Kim, J. M., Noh, E. M., Kwon, K. B., Kim, J. S., You, Y. O., Hwang, J. K.;, et al. (2012a). Curcumin suppresses the TPA-induced invasion through inhibition of PKCa-dependent MMP-expression in MCF-7 human breast cancer cells. Phytomedicine 19, 1085-1092. doi: 10.1016/j.phymed.2012.07.002
31. Kim, M. S., Kang, H. J., and Moon, A. (2001). Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch. Pharm. Res. 24, 349-354. doi: 10.1007/BF02975105
32. Kim, S. R., Park, H. J., Bae, Y. H., Ahn, S. C., Wee, H. J., Yun, I., et al. (2012b). Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion. Endocrinology 153, 554-563. doi: 10.1210/en.2011-1413
33. Kozuki, Y., Miura, Y., and Yagasaki, K. (2001). Inhibitory effect of curcumin on the invasion of rat ascites hepatoma cells in vitro and ex vivo. Cytotechnology 35, 57-63. doi: 10.1023/A:1008167502110
34. Kronski, E., Fiori, M. E., Barbieri, O., Astigiano, S., Mirisola, V., Killian, P. H., et al. (2014). miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and-2. Mol. Oncol. 8, 581-595. doi: 10.1016/j.molonc.2014.01.005
35. Kuttan, R., Bhanumathy, P., Nirmala, K., and George, M. C. (1985). Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 29, 197-202. doi: 10.1016/0304-3835(85)90159-4
36. Kwak, H. J., Park, M. J., Cho, H., Park, C. M., Moon, S. I., Lee, H. C., et al. (2006). Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol. Cancer Res. 4, 209-220. doi: 10.1158/1541-7786.MCR-05-0140
37. Lampe, V., and Milobedzka, J. (1913). Studien uber curcumin. Ber Dtsch. Chem. Ges. 46, 2235-2237. doi: 10.1002/cber.191304602149
38. Leow, P. C., Bahety, P., Boon, C. P., Lee, C. Y., Tan, K. L., Yang, T., et al. (2014). Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway. Eur. J. Med. Chem. 71, 67-80. doi: 10.1016/j.ejmech.2013.10.073
39. Leow, P. C., Tian, Q., Ong, Z. Y., Yang, Z., and Ee, P. L. R. (2010). Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells. Invest. New Drugs 28, 766-782. doi: 10.1007/s10637-009-9311-z
40. Lin, H. J., Su, C. C., Lu, H. F., Yang, J. S., Hsu, S. C., Ip, S. W., et al. (2010). Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2,-9, FAK, Rho A and Rock-1 gene expression. Oncol. Rep. 23, 665-670. doi: 10.3892/or_00000682
41. Lin, L. I., Ke, Y. F., Ko, Y. C., and Lin, J. K. (1998). Curcumin inhibits SK-hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 55, 349-353. doi: 10.1159/000011876
42. Lin, S. S., Lai, K. C., Hsu, S. C., Yang, J. S., Kuo, C. L., Lin, J. P., et al. (2009). Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett. 285, 127-133. doi: 10.1016/j.canlet.2009.04.037
43. Loeber, C. C., and Buechner, A. E. (1748). "Dissertatio inauguralis medica de curcuma officinarum ejusque genuinis virtutibus, " in Diss Inaug Halae, eds Præs. A. E. Büchnero (Halle: Halae Magdeburgicae), 28.
44. Lu, Y., Cai, Z., Galson, D. L., Xiao, G., Liu, Y., George, D. E., et al. (2006). Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 66, 1311-1318. doi: 10.1002/pros.20464
45. Luer, S., Troller, R, and Aebi, C. (2012). Antibacterial and antiinflammatory kinetics of curcumin as a potential antimucositis agent in cancer patients. Nutr. Cancer 64, 975-981. doi: 10.1080/01635581.2012.713161
46. Luer, S., Troller, R., Jetter, M., Spaniol, V., and Aebi, C. (2011). Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis? Support Care Cancer 19, 799-806. doi: 10.1007/s00520-010-0894-x
47. Luetke, A., Meyers, P. A., Lewis, I., and Juergens, H. (2014). Osteosarcoma treatment-where do we stand? a state of the art review. Cancer Treat Rev. 40, 523-532. doi: 10.1016/j.ctrv.2013.11.006
48. Milobedzka, J., Kostanecki, V., and Lampe, V. (1910). Zur Kenntnis des curcumins. Ber Dtsch. Chem. Ges. 43, 2163-2170. doi: 10.1002/cber.191004302168
49. National Cancer Institute. (1996). Clinical development plan: curcumin. J. Cell. Biochem. Suppl. 26, 72-85.
50. Newman, D. J., and Cragg, G. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335. doi: 10.1021/np200906s
51. Oppenheimer, A. (1937). Turmeric (curcumin) in biliary diseases. Lancet 229, 619-621. doi: 10.1016/S0140-6736(00)98193-5
52. Padhye, S., Chavan, D., Pandey, S., Deshpande, J., Swamy, K. V., and Sarkar, F. H. (2010). Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini. Rev. Med. Chem. 10, 372-387. doi: 10.2174/138955710791330891
53. Payton, F., Sandusky, P., and Alworth, W. L. (2007). NMR study of the solution structure of curcumin. J. Nat. Prod. 70, 143-146. doi: 10.1021/np060263s
54. Piccolella, M., Crippa, V., Messi, E., Tetel, M. J., and Poletti, A. (2014). Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells. Pharmacol. Res. 79, 13-20. doi: 10.1016/j.phrs.2013.10.002
55. Ploto, A. (2003). Turmeric: Post-Production Management for Improved Market Access for Herbs and Spices-Turmeric. Rome: Food and Agriculture Organization of the United Nations (FAO).
56. Prasad, C. P., Rath, G., Mathur, S., Bhatnagar, D., and Ralhan, R. (2010). Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines. Chem. Biol. Interact. 183, 455-461. doi: 10.1016/j.cbi.2009.11.019
57. Radhakrishnan, V. M., Kojs, P., Young, G., Ramalingam, R., Bhumasamudram, J., Mash, E. A., et al. (2014). pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1). PLoS ONE 9:e 85796. doi: 10.1371/journal.pone.0085796
58. Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., et al. (2012). Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res. Ther. 4:43. doi: 10.1186/alzrt146
59. Rothschild, B. M., Tanke, D., Hershkovitz, I., and Schultz, M. (1998). Mesozoic neoplasia: origins of haemangioma in the Jurassic age. Lancet 351, 1862-1862. doi: 10.1016/S0140-6736(05)78809-7
60. Rothschild, B. M., Tanke, D. H., Helbling, M., and Martin, L. D. (2003). Epidemiologic study of tumors in dinosaurs. Naturwissenschaften 90, 495-500. doi: 10.1007/s00114-003-0473-9
61. Rothschild, B. M., Witzke, B. J., and Hershkovitz, I. (1999). Metastatic cancer in the jurassic. Lancet, 354, 398-398. doi: 10.1016/S0140-6736(99)01019-3
62. Roughley, P. J., and Whiting, D. A. (1973). Experiments in the biosynthesis of curcumin. J. Chem. Soc. Perkin Trans. 1, 2379-2388. doi: 10.1039/p19730002379
63. Salvioli, S., Sikora, E., Cooper, E. L., and Franceschi, C. (2007). Curcumin in cell death processes: a challenge for CAM of age related pathologies. Evid. Based Complement. Alternat. Med. 4, 181-190. doi: 10.1093/ecam/nem043
64. Schraufstatter, E., and Bernt, H. (1949). Antibacterial action of curcumin and related compounds. Nature 164, 456-457. doi: 10.1038/164456a0
65. Senft, C., Polacin, M., Priester, M., Seifert, V., Kogel, D., and Weissenberger, J. (2010). The nontoxic natural compound curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer 10:491. doi: 10.1186/1471-2407-10-491
66. Shao, Z. M., Shen, Z. Z., Liu, C. H., Sartippour, M. R., Go, V. L., Heber, D., et al. (2002). Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int. J. Cancer 98, 234-240. doi: 10.1002/ijc.10183
67. Shoji, M., Nakagawa, K., Watanabe, A., Tsuduki, T., Yamada, T., Kuwahara, S., et al. (2014). Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells. Food Chem. 151, 126-132. doi: 10.1016/j.foodchem.2013.11.021
68. Siripong, P., Nakamura, E. S., Kanokmedhakul, K., Ruchirawat, S., and Saiki, I. (2002). Anti-invasive effects of curcuminoid compounds from Curcuma aromatica Salisb. on murine colon 26-L5 carcinoma cells. Wa-kan-iyakugaku-zasshi 19, 209-215.
69. Srinivasan, K. R. (1953). A chromatographic study of the curcuminoids in Curcuma longa, L. J. Pharm. Pharmacol. 5, 448-457. doi: 10.1111/j.2042-7158.1953.tb14007.x
70. Thomas, M. B., and Abbruzzese, J. L. (2005). Opportunities for targeted therapies in hepatocellular carcinoma. J. Clin. Oncol. 23, 8093-8108. doi: 10.1200/JCO.2004.00.1537
71. Vogel, A. (1842). Mémoire sur la Curcumine. J. de Pharm. et Chim. 2, 20-27.
72. Vogel, H. A., and Pelletier, J. (1815). Chemische Untersuchung der Gilbwurzel (Kurkume). J. Pharma. 7, 20.
73. Vogelstein, B., and Kinzler, K. W. (2004). Cancer genes and the pathways they control. Nat. Med. 10, 789-799. doi: 10.1038/nm1087
74. Wang, S., Yu, S., Shi, W., Ge, L., Yu, X., Fan, J., et al. (2011). Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life 63, 775-782. doi: 10.1002/iub.507
75. World Health Organization. (1999). "Rhizoma curcumae longae, " in WHO Monographs on Selected Medicinal Plants, Vol. 1 (Geneva: WHO), 115-124.
76. Wu, H., Reynolds, A. B., Kanner, S. B., Vines, R. R., and Parsons, J. T. (1991). Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol. Cell. Biol. 11, 5113-5124.
77. Xu, M.X., Zhao, L., Deng, C., Yang, L., Wang, Y., Guo, T., et al. (2013). Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the Wnt signaling pathway. Int. J. Oncol. 43, 1951-1959. doi: 10.3892/ijo.2013.2107
78. Yang, C. L., Liu, Y. Y., Ma, Y. G., Xue, Y. X., Liu, D. G., Ren, Y., et al. (2012). Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus Kinase-STAT3 signaling pathway. PLoS ONE 7:e37960. doi: 10.1371/journal.pone.0037960
79. Zong, H., Wang, F., Fan, Q. X., and Wang, L. X. (2012). Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol. Biol. Rep. 39, 4803-4808. doi: 10.1007/s11033-011-1273-5